MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer Operating Cycle 2011-2026 | PKI
Annual Operating Cycle PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.2 | 87.6 | 92.9 | 91.3 | 250 | - | 179 | 169 | 155 | 155 | - | 161 | 159 | 160 | 156 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 87.6 | 147 |
Quarterly Operating Cycle PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 196 | 188 | 204 | - | 203 | 200 | 216 | - | 220 | 207 | 211 | - | 245 | 264 | 244 | 71.6 | 259 | 161 | 80.4 | - | 172 | 184 | 195 | 83.3 | 183 | 179 | 189 | 76.3 | 176 | 167 | 173 | 78.5 | 203 | 203 | 187 | 68.7 | 182 | 173 | 94.5 | - | 159 | 155 | 167 | 70.6 | 166 | 162 | 165 | 72 | 164 | 159 | 166 | 72.8 | 163 | 160 | 147 | 69.5 | 156 | 145 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 264 | 68.7 | 163 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
161 | $ 113.88 | -0.84 % | $ 34.6 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 24.83 | 0.4 % | $ 690 M | USA |
 |
Danaher Corporation
DHR
|
143 | $ 191.01 | -0.56 % | $ 136 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.91 | -3.11 % | $ 481 M | USA |
 |
Guardant Health
GH
|
128 | $ 93.3 | 4.06 % | $ 11.7 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.67 | -0.84 % | $ 942 M | USA |
 |
DexCom
DXCM
|
202 | $ 63.11 | -0.16 % | $ 24.6 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 107.16 | -2.24 % | $ 8.84 B |  Irlanda |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.09 | -1.29 % | $ 173 M |  China |
 |
IQVIA Holdings
IQV
|
73.9 | $ 170.62 | -0.01 % | $ 29.3 B | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 269.17 | -1.93 % | $ 22.4 B | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 78.08 | 2.89 % | $ 5.27 B | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Medpace Holdings
MEDP
|
50.4 | $ 508.52 | 2.52 % | $ 14.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 169.54 | 0.78 % | $ 8.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 270.0 | 0.27 % | $ 26.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.74 | 1.5 % | $ 439 M | USA |
 |
NeoGenomics
NEO
|
102 | $ 8.06 | 0.5 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 9.98 | 4.39 % | $ 2.16 B | USA |
 |
Natera
NTRA
|
81.5 | $ 209.27 | 2.15 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 14.53 | -5.4 % | $ 1.88 B | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
244 | $ 1.44 | 1.41 % | $ 432 M | USA |
 |
Precipio
PRPO
|
43.8 | $ 28.5 | 9.7 % | $ 45.7 M | USA |
 |
Personalis
PSNL
|
55.8 | $ 6.17 | -6.23 % | $ 366 M | USA |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Illumina
ILMN
|
198 | $ 126.44 | -1.02 % | $ 20.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.69 | 3.86 % | $ 87.3 K | USA |
 |
Biomerica
BMRA
|
204 | $ 2.16 | -0.46 % | $ 4.96 M | USA |
 |
BioNano Genomics
BNGO
|
315 | $ 1.17 | 1.74 % | $ 6.37 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 2.0 | 1.27 % | $ 8.85 M | USA |